HUP0002876A2 - 5-(2-Etil-2H-tetrazol-5-il)-1-metil-1,2,3,6-tetrahidro-piridin-maleát, e vegyületet tartalmazó gyógyászati készítmény és alkalmazása - Google Patents
5-(2-Etil-2H-tetrazol-5-il)-1-metil-1,2,3,6-tetrahidro-piridin-maleát, e vegyületet tartalmazó gyógyászati készítmény és alkalmazásaInfo
- Publication number
- HUP0002876A2 HUP0002876A2 HU0002876A HUP0002876A HUP0002876A2 HU P0002876 A2 HUP0002876 A2 HU P0002876A2 HU 0002876 A HU0002876 A HU 0002876A HU P0002876 A HUP0002876 A HU P0002876A HU P0002876 A2 HUP0002876 A2 HU P0002876A2
- Authority
- HU
- Hungary
- Prior art keywords
- tetrazol
- ethyl
- methyl
- pharmaceutical composition
- composition containing
- Prior art date
Links
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 title abstract 3
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 150000003839 salts Chemical class 0.000 abstract 3
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 abstract 2
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 abstract 2
- 229960004373 acetylcholine Drugs 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 239000011976 maleic acid Substances 0.000 abstract 2
- RNMOMKCRCIRYCZ-UHFFFAOYSA-N Alvameline Chemical compound CCN1N=NC(C=2CN(C)CCC=2)=N1 RNMOMKCRCIRYCZ-UHFFFAOYSA-N 0.000 abstract 1
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 230000007257 malfunction Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000003551 muscarinic effect Effects 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK78197 | 1997-07-01 | ||
| PCT/DK1998/000294 WO1999001448A1 (en) | 1997-07-01 | 1998-07-01 | 5-(2-ethyl-2h-tetrazol-5-y1)-1-methyl-1,2,3,6-tetrahydropyridine maleate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUP0002876A2 true HUP0002876A2 (hu) | 2001-06-28 |
Family
ID=8097489
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0002876A HUP0002876A2 (hu) | 1997-07-01 | 1998-07-01 | 5-(2-Etil-2H-tetrazol-5-il)-1-metil-1,2,3,6-tetrahidro-piridin-maleát, e vegyületet tartalmazó gyógyászati készítmény és alkalmazása |
Country Status (25)
| Country | Link |
|---|---|
| EP (1) | EP0994869A1 (tr) |
| JP (1) | JP2002507215A (tr) |
| KR (1) | KR20010014297A (tr) |
| CN (1) | CN1261361A (tr) |
| AR (1) | AR013096A1 (tr) |
| AU (1) | AU735751B2 (tr) |
| BG (1) | BG103933A (tr) |
| BR (1) | BR9810331A (tr) |
| CA (1) | CA2293324A1 (tr) |
| CO (1) | CO4940483A1 (tr) |
| EA (1) | EA200000081A1 (tr) |
| HU (1) | HUP0002876A2 (tr) |
| IL (1) | IL133093A0 (tr) |
| IS (1) | IS5278A (tr) |
| JO (1) | JO2031B1 (tr) |
| MA (1) | MA25138A1 (tr) |
| NO (1) | NO996580D0 (tr) |
| PE (1) | PE116099A1 (tr) |
| PL (1) | PL337184A1 (tr) |
| SK (1) | SK187399A3 (tr) |
| TN (1) | TNSN98120A1 (tr) |
| TR (1) | TR199903283T2 (tr) |
| UY (2) | UY25069A1 (tr) |
| WO (1) | WO1999001448A1 (tr) |
| ZA (1) | ZA985498B (tr) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8714789D0 (en) * | 1987-06-24 | 1987-07-29 | Lundbeck & Co As H | Heterocyclic compounds |
| WO1997017074A1 (en) * | 1995-11-06 | 1997-05-15 | H. Lundbeck A/S | Treatment of traumatic brain injury |
-
1998
- 1998-06-18 AR ARP980102925A patent/AR013096A1/es not_active Application Discontinuation
- 1998-06-24 ZA ZA985498A patent/ZA985498B/xx unknown
- 1998-06-25 PE PE1998000563A patent/PE116099A1/es not_active Application Discontinuation
- 1998-06-25 JO JO19982031A patent/JO2031B1/en active
- 1998-06-26 CO CO98036576A patent/CO4940483A1/es unknown
- 1998-06-29 UY UY25069A patent/UY25069A1/es not_active Application Discontinuation
- 1998-06-30 TN TNTNSN98120A patent/TNSN98120A1/fr unknown
- 1998-07-01 KR KR1019997012429A patent/KR20010014297A/ko not_active Application Discontinuation
- 1998-07-01 EA EA200000081A patent/EA200000081A1/ru unknown
- 1998-07-01 CN CN98806497A patent/CN1261361A/zh active Pending
- 1998-07-01 SK SK1873-99A patent/SK187399A3/sk unknown
- 1998-07-01 EP EP98930655A patent/EP0994869A1/en not_active Withdrawn
- 1998-07-01 JP JP50616699A patent/JP2002507215A/ja active Pending
- 1998-07-01 MA MA25155A patent/MA25138A1/fr unknown
- 1998-07-01 PL PL98337184A patent/PL337184A1/xx unknown
- 1998-07-01 AU AU81020/98A patent/AU735751B2/en not_active Ceased
- 1998-07-01 TR TR1999/03283T patent/TR199903283T2/tr unknown
- 1998-07-01 HU HU0002876A patent/HUP0002876A2/hu unknown
- 1998-07-01 BR BR9810331-8A patent/BR9810331A/pt not_active Application Discontinuation
- 1998-07-01 CA CA002293324A patent/CA2293324A1/en not_active Abandoned
- 1998-07-01 IL IL13309398A patent/IL133093A0/xx unknown
- 1998-07-01 WO PCT/DK1998/000294 patent/WO1999001448A1/en not_active Application Discontinuation
- 1998-09-10 UY UY25177A patent/UY25177A1/es not_active Application Discontinuation
-
1999
- 1999-11-30 IS IS5278A patent/IS5278A/is unknown
- 1999-11-30 BG BG103933A patent/BG103933A/xx unknown
- 1999-12-30 NO NO996580A patent/NO996580D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| BR9810331A (pt) | 2000-09-05 |
| EP0994869A1 (en) | 2000-04-26 |
| CN1261361A (zh) | 2000-07-26 |
| UY25177A1 (es) | 2000-12-29 |
| MA25138A1 (fr) | 2001-04-02 |
| IS5278A (is) | 1999-11-30 |
| AU735751B2 (en) | 2001-07-12 |
| EA200000081A1 (ru) | 2000-08-28 |
| PL337184A1 (en) | 2000-08-14 |
| KR20010014297A (ko) | 2001-02-26 |
| AU8102098A (en) | 1999-01-25 |
| SK187399A3 (en) | 2000-06-12 |
| PE116099A1 (es) | 1999-11-23 |
| IL133093A0 (en) | 2001-03-19 |
| NO996580L (no) | 1999-12-30 |
| TNSN98120A1 (fr) | 2005-03-15 |
| CA2293324A1 (en) | 1999-01-14 |
| ZA985498B (en) | 1999-01-20 |
| CO4940483A1 (es) | 2000-07-24 |
| AR013096A1 (es) | 2000-12-13 |
| WO1999001448A1 (en) | 1999-01-14 |
| JP2002507215A (ja) | 2002-03-05 |
| UY25069A1 (es) | 1998-12-21 |
| JO2031B1 (en) | 1999-05-15 |
| NO996580D0 (no) | 1999-12-30 |
| TR199903283T2 (tr) | 2000-06-21 |
| BG103933A (en) | 2000-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE119040T1 (de) | Zentrale cholecystokinin-antagonisten zur behandlung von psychiatrischen krankheiten. | |
| NO20053855D0 (no) | 1-fenylalkankarboksylsyrederivater til behandling av neurodegenerative sykdommer. | |
| PT1311285E (pt) | Composicao farmaceutica liquida contendo um derivado de eritropoietina | |
| CA2318128A1 (en) | Oral liquid compositions | |
| BG101118A (en) | Therapeutical compounds | |
| CA2235747A1 (en) | Use of 1-(2-naphth-2-ylethyl)-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine for preparing drugs for treating amyotrophic lateral sclerosis | |
| CA2132544A1 (en) | Angiotensin ii antagonists against disorders associated with impaired neuronal conduction velocity, especially diabetic neuropathy | |
| WO2002060435A8 (fr) | Cryptotanshinone permettant de prevenir et d'attenuer la maladie d'alzheimer | |
| TR200000455T2 (tr) | Alzheimer hastalığının tedavisinde fankinonun kullanılması. | |
| CA2217513A1 (en) | Pharmaceutical agents for the treatment of alzheimer's disease | |
| BR9711259A (pt) | Droga preventiva ou terapeutica para doen-a de alzheimer | |
| AU6415994A (en) | Substituted caprolactams and derivatives thereof useful for treatment of hiv disease | |
| NO903384D0 (no) | Fremgangsmaate for fremstilling av 4-(n-substituert amino)-2-butynyl-1-urinstoffer og -tiourinstoffer og derivater derav. | |
| NO20000519L (no) | 2-acylaminopropanaminer som takykininreseptorantagonister | |
| ES2162520T3 (es) | Medicamentos basados en hiperforina y/o extractos de hiperforina. | |
| HUP0002876A2 (hu) | 5-(2-Etil-2H-tetrazol-5-il)-1-metil-1,2,3,6-tetrahidro-piridin-maleát, e vegyületet tartalmazó gyógyászati készítmény és alkalmazása | |
| WO1999020291A3 (en) | Pharmaceutical grade ginkgo biloba | |
| DE60306503D1 (de) | Statin-therapie zur verbesserung der aufrechterhaltung der kognitiven funktion | |
| IL112666A (en) | 4-Amino derivatives of 5-substituted mycophenolic acid their preparation and pharmaceutical compositions containing them | |
| TR199901385T2 (tr) | Piperidin türevleri. | |
| WO1999021005A3 (en) | Pharmaceutical grade st. john's wort | |
| WO2003000717A3 (de) | Identifizierung von ses-3 (spr-5) aus c. elegans sowie dessen verwendungen | |
| WO1998036758A3 (de) | Sauerstoffanionradikale enthaltende therapeutische mittel und deren verwendung zur behandlung von morbus parkinson | |
| WO2003000889A3 (de) | Identifizierung von ses-1 aus c. elegans sowie dessen verwendung | |
| ES2127133A1 (es) | Utilizacion de derivados 2,5-dihidroxibencenosulfonicos para la fabricacion de medicamentos destinados al tratamiento y a la prevencion de la enfermedad de alzheimer. |